Feng-Shuang Yi

Dr. Feng-Shuang Yi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
MSMing-Ming Shao
Ming-Ming Shao
MSMeier Shi
Meier Shi
JDJuan Du
Juan Du
XPXue-Bin Pei
Xue-Bin Pei
BGBei-Bei Gu
Bei-Bei Gu
FYFeng-Shuang Yi
Feng-Shuang Yi
Abnormal function of immune cells is one of the key mechanisms leading to severe clinical symptoms in coronavirus disease 2019 patients, and metabolic pathways can destroy the function of the immune system by affecting innate and adaptive immune responses. However, the metabolic characteristics of the immune cells of the SARS-CoV-2 infected organs in situ remaining elusive. We reanalyzed the metabolic-related gene profiles in single-cell RNA sequencing data, drew the metabolic landscape in bronchoalveolar lavage fluid immune cells, and elucidated the metabolic remodeling mechanism that might lead to the progression of COVID-19 and the cytokine storm. Enhanced glycolysis is the most important common metabolic feature of all immune cells in COVID-19 patients. CCL2+ T cells, Group 2 macrophages with high SPP1 expression and myeloid dendritic cells are among the main contributors to the cytokine storm produced by infected lung tissue. Two metabolic analysis methods, including Compass, showed that glycolysis, fatty acid metabolism, bile acid synthesis and purine and pyrimidine metabolism levels of CCL2+ T cells, Group 2 macrophages and myeloid dendritic cells were upregulated and correlated with cytokine storms of COVID-19 patients. This might be the key metabolic regulatory factor for immune cells to produce large quantities of cytokines.

2 May 2025 in Respiratory Research
Verified
Journal Article
Open access
PDF file
QCQing-Yu Chen
Qing-Yu Chen
SYShu-Min Yin
Shu-Min Yin
MSMing-Ming Shao
Ming-Ming Shao
FYFeng-Shuang Yi
Feng-Shuang Yi
HSHuan-Zhong Shi
Huan-Zhong Shi
Classification of the etiologies of pleural effusion is a critical challenge in clinical practice. Traditional diagnostic methods rely on a simple cut-off method based on the laboratory tests. However, machine learning (ML) offers a novel approach based on artificial intelligence to improving diagnostic accuracy and capture the non-linear relationships. A retrospective study was conducted using data from patients diagnosed with pleural effusion. The dataset was divided into training and test set with a ratio of 7:3 with 6 machine learning algorithms implemented to diagnosis pleural effusion. Model performances were assessed by accuracy, precision, recall, F1 scores and area under the receiver operating characteristic curve (AUC). Feature importance and average prediction of age, Adenosine (ADA) and Lactate dehydrogenase (LDH) was analyzed. Decision tree was visualized. A total of 742 patients were included (training cohort: 522, test cohort: 220), 397 (53.3%) diagnosed with malignant pleural effusion (MPE) and 253 (34.1%) with tuberculous pleural effusion (TPE) in the cohort. All of the 6 models performed well in the diagnosis of MPE, TPE and transudates. Extreme Gradient Boosting and Random Forest performed better in the diagnosis of the MPE, with F1 scores above 0.890, while K-Nearest Neighbors and Tabular Transformer performed better in the diagnosis of the TPE, with F1 scores above 0.870. ADA was identified as the most important feature. The ROC of machine learning model outperformed those of conventional diagnostic thresholds. This study demonstrates that ML models using age, ADA, and LDH can effectively classify the etiologies of pleural effusion, suggesting that ML-based approaches may enhance diagnostic decision-making.

1 November 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
XQXin Qiao
Xin Qiao
MSMing-Ming Shao
Ming-Ming Shao
FYFeng-Shuang Yi
Feng-Shuang Yi
HSHuan-Zhong Shi
Huan-Zhong Shi
Background and Objective:The accurate differential diagnosis of tuberculous pleural effusion (TPE) from other exudative pleural effusions is often challenging. We aimed to validate the accuracy of complement component C1q in pleural fluid (PF) in diagnosing TPE.Methods:The level of C1q protein in the PF from 49 patients with TPE and 61 patients with non-tuberculous pleural effusion (non-TPE) was quantified by enzyme-linked immunosorbent assay, and the diagnostic performance was assessed by receiver operating characteristic (ROC) curves based on the age and gender of the patients.Results:The statistics showed that C1q could accurately diagnose TPE. Regardless of age and gender, with a cutoff of 6,883.9 ng/mL, the area under the curve (AUC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of C1q for discriminating TPE were 0.898 (95% confidence interval: 0.825–0.947), 91.8 (80.4–97.7), 80.3 (68.2–89.4), 78.9 (69.2–86.2), and 92.5 (82.6–96.9), respectively. In subgroup analysis, the greatest diagnostic accuracy was achieved in the younger group (≤ 50 years of age) with an AUC of 0.981 (95% confidence interval: 0.899–0.999) at the cutoff of 6,098.0 ng/mL. The sensitivity, specificity, PLR, NLR, PPV, and NPV of C1q were 95.0 (83.1–99.4), 92.3 (64.0–99.8), 97.4 (85.2–99.6), and 85.7 (60.6–95.9), respectively.Conclusion:Complement component C1q protein was validated by this study to be a promising biomarker for diagnosing TPE with high diagnostic accuracy, especially among younger patients.

1 June 2021 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
XZXin Zhang
Xin Zhang
FYFeng-Shuang Yi
Feng-Shuang Yi
HSHuan-Zhong Shi
Huan-Zhong Shi
Background: Malignant pleural effusion (MPE) is a frequent complication of advanced malignancies that leads to a poor quality of life and limits treatment options. Objective: The objective of this study was to identify biomarkers of survival in patients with MPE, which will greatly facilitate the clinical management of this complication. Methods: This retrospective study recruited patients who had been pathologically diagnosed with MPE, regardless of the type of primary cancer, at Beijing Chao-Yang Hospital over 158 months. Demographic, clinical, hematological, and pleural fluid data were collected and analyzed as potential predictors of survival, and a new predictive model was developed based on Cox and logistic regression analyses. Results: In our alternative prognostic model (n = 281), four routinely detected variables, namely, carcinoembryonic antigen (CEA) level, monocyte count, N-terminal pro B-type natriuretic peptide (NT-pro-BNP) level, and pleural effusion chloride level on admission, were identified as predictors (the CONCH prognostic score). Patients were divided into three prognosis subgroups based on risk stratification, with median survival periods of 17, 11, and 5 months, respectively. In comparison with the low-risk group, patients in the medium- and high-risk groups showed significantly poorer survival (medium-risk group: hazard ratio [HR], 1.586; 95% confidence interval [CI], 1.047– 2.402; P = 0.029; high-risk group: HR, 4.389; 95% CI, 2.432– 7.921; P < 0.001). Conclusion: Four routinely detected variables were used to develop the CONCH scoring system, which was confirmed to be an accurate prognostic score for patients with MPE. This system can guide the selection of interventions and management for MPE.

10 January 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
XQXin Qiao
Xin Qiao
ZZZhi-Rong Zhang
Zhi-Rong Zhang
XSXin-Yu Shi
Xin-Yu Shi
FYFeng-Shuang Yi
Feng-Shuang Yi
Objective: Pre-treatment biomarkers to estimate overall survival (OS) for malignant pleural effusion (MPE) are unidentified, especially those in pleural fluid. We evaluated the relationship between OS and total protein–chloride ratio in malignant pleural effusion (PE TPClR).Materials and Methods: A retrospective study was undertaken to identify patients from 2006 to 2018 who had pathologically or cytologically confirmed MPE and received no tumor-targeted therapy. We recorded the pre-treatment clinicopathologic characteristics and follow-up status. OS was estimated by the Kaplan–Meier method, and the association between variables and OS was evaluated by Cox proportional hazards models.Results: We screened 214 patients who met the eligibility criteria. The optimal cutoff value for the PE TPClR was set at 0.53. The univariate analysis showed that there was a significant correlation between PE TPClR and OS (P < 0.001). The multivariate analysis between OS and the variables selected from the univariate analysis showed that the levels of neutrophil, alkaline phosphatase, neuron-specific enolase, platelets, albumin in peripheral blood, and white blood cells in pleural effusion were also independent predictors of OS.Conclusion: In patients with MPE, pre-treatment PE TPClR independently predicts OS. Although further research is necessary to generalize our results, this information will help clinicians and patients to determine the most appropriate treatment for MPE patients.

1 August 2025 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
XSXin-Yu Shi
Xin-Yu Shi
YZYi-Xiao Zhang
Yi-Xiao Zhang
SDShu-Feng Dong
Shu-Feng Dong
QCQing-Yu Chen
Qing-Yu Chen
FYFeng-Shuang Yi
Feng-Shuang Yi
Background: In regions with a high prevalence of tuberculosis, it is crucial to accurately differentiate between tuberculosis pleural effusion (TPE) and parapneumonic effusion (PPE). The current study aimed to evaluate the potential role of the pleural fluid lactate dehydrogenase (LDH)/adenosine deaminase (ADA) ratio in differentiating between TPE and PPE. Methods: In the first section, the pleural fluid LDH/ADA ratio was compared between 45 patients with TPE and 81 patients with PPE within our study population, and its diagnostic efficacy was assessed. In the second section, we conducted a meta-analysis incorporating six previous publications and the current study. Results: In our study population, a cut-off value of 18.63 for the pleural fluid LDH/ADA ratio was established for diagnostic performance analysis. The area under the curve (AUC) to discriminate between TPE and PPE was 0.960 [95% confidence interval (CI): 0.902 to 0.989]. As for sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), positive predictive value and negative predictive value, they were 94.44% (95% CI: 81.3% to 99.3%), 84.85% (95% CI: 73.9% to 92.5%), 6.23 (95% CI: 3.50 to 11.09), 0.065 (95% CI: 0.017 to 0.25), 77.3% (95% CI: 65.6% to 85.8%), and 96.6% (95% CI: 87.9% to 99.1%), respectively. The diagnostic accuracy of the pleural fluid LDH/ADA ratio was further tested and confirmed in the subsequent meta-analysis. The meta-analysis demonstrated that the pooled sensitivity and specificity were 90% (95% CI: 82% to 94%) and 91% (95% CI: 84% to 95%), respectively. Conclusions: The current study suggests that the pleural fluid LDH/ADA ratio is a useful marker for distinguishing TPE from PPE.